Delivery Order SPE2DB22D2211-SPE2DB25FRNFC
Award Date
1/3/25
Potential Completion Date
1/6/25
Potential Value
$5.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,305.89 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of January 6, 2025 and was awarded on January 3, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,515.80 firm fixed-price delivery order contract provides for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product used in the treatment of diabetes. The contract has an ultimate completion date of November 5, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $5,920.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product, with a completion date of January 3, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $2,605.50, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, with a completion date of October 25, 2024. This award is a part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,781.36, is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of July 18, 2023.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, covers the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a critical medical product. The $2,722.80 firm fixed price delivery order has a performance period through March 30, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,521.48 firm-fixed-price delivery order is for the supply of 4,566,361,756 units of the medication NOVOLOG 10ML VIAL 1S. The contract has an ultimate completion date of December 6, 2024 and was awarded on November 7, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery...
This federal contract award, valued at $1,439.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product used for various healthcare needs. The contract is a Firm Fixed Price arrangement with an ultimate completion date of October 24, 2024.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,092.28 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FNZ70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,500.54, is a delivery order for the procurement of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of January 6, 2025.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...